drugset / Trial / NCT00882726
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of CNTO 3649 following a single dose in healthy adults and following multiple doses in patients with Type 2 Diabetes Mellitus.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CNTO 3649 | Unknown | 1 ug/kg | Intravenous |
| Subject | CNTO 3649 | Unknown | 3 ug/kg | Intravenous |
| Subject | CNTO 3649 | Unknown | 10 ug/kg | Intravenous |
| Subject | CNTO 3649 | Unknown | 30 ug/kg | Intravenous |
| Subject | CNTO 3649 | Unknown | 100 ug/kg | Intravenous |
| Subject | CNTO 3649 | Unknown | 300 ug/kg | Intravenous |